A major cause of morbidity and mortality in the context of the antiphospholipid syndrome
(APS) is the occurrence of thrombotic events. Besides the pathogenic roles of …

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
venous, arterial or microvascular thrombosis or obstetric events in the presence of …

The antiphospholipid syndrome (APS) is an autoimmune systemic disease characterized by
a hypercoagulable state secondary to the presence of antiphospholipid antibodies (aPL) …

Antiphospholipid syndrome (APS) encompasses a wide spectrum of disease manifestations
that may prevail in the form of venous or arterial thrombosis or lead to pregnancy …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence
of antiphospholipid antibodies (aPL)(lupus anticoagulant, anticardiolipin antibodies and anti …

Despite the strong association between antiphospholipid antibodies (aPL) and thrombosis,
the pathogenic role of aPL in the development of thrombosis has not been fully elucidated …

Introduction Antiphospholipid syndrome (APS) is a pro-thrombotic autoimmune disease that
affects different vascular beds, with potential risk for recurrence. Systemic lupus …

Although much progress has been made in the past 20 years on understanding the clinical
features of antiphospholipid syndrome (APS), investigation into its epidemiology has been …

Antiphospholipid syndrome (APS) is a systemic disorder clinically characterized by
widespread thrombosis and obstetric complications associated with the persistent presence …

The presence of antiphospholipid antibodies has been shown to be related to an increased
risk of thrombotic events. In patients with definite antiphospholipid syndrome (APS), that is …